Monte Rosa Therapeutics, Inc.
GLUE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001826457
In the last 90 days, Monte Rosa Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 192 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in Monte Rosa Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 129
- +13 vs. Q2 2025
- Shares held
- 60.0M
- −2.17M (−3.5%) vs. Q2 2025
- Total value
- $444.9M
- +$164.3M (+58.6%) vs. Q2 2025
- New holders
- 27
- 35 more added
- Sold out
- 14
- 41 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GLUE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 192 | $2.24B |
| Q1 2026 | 191 | $1.43B |
| Q4 2025 | 161 | $1.01B |
| Q3 2025 | 129 | $444.9M |
| Q2 2025 | 116 | $280.6M |
| Q1 2025 | 106 | $276.2M |
| Q4 2024 | 105 | $423.3M |
| Q3 2024 | 81 | $263.7M |
| Q2 2024 | 75 | $171.7M |
| Q1 2024 | 68 | $281.3M |
| Q4 2023 | 71 | $226.6M |
| Q3 2023 | 71 | $201.4M |
| Q2 2023 | 68 | $272.3M |
| Q1 2023 | 69 | $309.8M |
| Q4 2022 | 66 | $313.8M |
| Q3 2022 | 70 | $328.8M |
| Q2 2022 | 57 | $375.0M |
| Q1 2022 | 52 | $559.9M |
| Q4 2021 | 53 | $742.0M |
| Q3 2021 | 56 | $759.4M |
| Q2 2021 | 48 | $705.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Monte Rosa Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bridgeway Capital Management, LLC | 358,850 | $2.66M | 0.06% | +87,450+32.2% | Added |
| Charles Schwab Investment Management Inc | 383,268 | $2.84M | 0.00% | +1,931+0.5% | Added |
| Renaissance Technologies LLC | 395,733 | $2.93M | 0.00% | −219,367−35.7% | Reduced |
| Balyasny Asset Management LLC | 408,540 | $3.03M | 0.01% | +408,540 | New |
| Royal Bank of Canada | 435,767 | $3.23M | 0.00% | −34,031−7.2% | Reduced |
| Millennium Management LLC | 444,939 | $3.30M | 0.00% | +380,308+588.4% | Added |
| American Century Companies Inc | 593,394 | $4.40M | 0.00% | +190,349+47.2% | Added |
| Dimensional Fund Advisors LP | 632,182 | $4.68M | 0.00% | +184,020+41.1% | Added |
| Morgan Stanley | 645,196 | $4.78M | 0.00% | +74,746+13.1% | Added |
| Silverarc Capital Management, LLC | 694,942 | $5.15M | 0.75% | +694,942 | New |
| Parkwood LLC | 708,000 | $5.25M | 0.51% | 00.0% | Unchanged |
| AQR Capital Management LLC | 717,262 | $5.31M | 0.00% | −566,680−44.1% | Reduced |
| Northern Trust Corp | 740,684 | $5.49M | 0.00% | −20,735−2.7% | Reduced |
| Vestal Point Capital, LP | 800,000 | $5.93M | 0.27% | +800,000 | New |
| State Street Corp | 846,773 | $6.27M | 0.00% | +14,954+1.8% | Added |
| Marshall Wace, LLP | 902,834 | $6.69M | 0.01% | +456,754+102.4% | Added |
| Geode Capital Management, LLC | 1,151,566 | $8.53M | 0.00% | +27,406+2.4% | Added |
| Alphabet Inc. | 1,464,015 | $10.8M | 0.45% | 00.0% | Unchanged |
| Aisling Capital Management LP | 1,472,331 | $10.9M | 2.39% | 00.0% | Unchanged |
| FMR LLC | 2,812,251 | $20.8M | 0.00% | +524,217+22.9% | Added |
| Vanguard Group Inc | 2,988,953 | $22.1M | 0.00% | −151,557−4.8% | Reduced |
| Suvretta Capital Management, LLC | 3,360,000 | $24.9M | 0.75% | 00.0% | Unchanged |
| BlackRock, Inc. | 3,815,133 | $28.3M | 0.00% | −31,321−0.8% | Reduced |
| Price T Rowe Associates Inc | 4,637,060 | $34.4M | 0.00% | −1,688,598−26.7% | Reduced |
| Baker Bros. Advisors LP | 4,916,095 | $36.4M | 0.26% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 5,652,922 | $41.9M | 19.72% | 00.0% | Unchanged |
| BVF Inc | 5,660,132 | $41.9M | 1.70% | 00.0% | Unchanged |
| NEA Management Company, LLC | 7,692,298 | $57.0M | 3.13% | 00.0% | Unchanged |
| Summit Wealth Group LLC | 2,002 | – | – | +2,002 | New |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −3,725,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −109,227−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −60,100−100.0% | Sold out |
| Integrated Quantitative Investments LLC | 0 | $0 | 0.00% | −35,400−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −24,100−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −21,867−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −12,958−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −10,857−100.0% | Sold out |
| Brighton Jones LLC | 0 | $0 | 0.00% | −10,559−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1,066−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −92−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |